hotspot -WSS

hotspot

author：leisure time 2025-08-12 09:11:00 - browse：49664

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Evacuations in place as 3 wildfires burn in eastern Washington state

Wikipedia

leisure time

WSS

Hilary may become 1st tropical storm to make landfall in California in 84 years

Baltimore teen accused of firing into crowd during block party mass shooting

Ukraine taking heavy casualties 10 weeks into its counteroffensive

FTC falls short on scrutinizing hospital mergers, study says

After traumatic brain injury, life support decisions can use more time

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

focus

hotspot

hotspot

Cancer drug shortages should be causing more outrage

Melinda French Gates resigns from Gates Foundation

Jerome Adams on the need for new antivirals for Covid

Close Medicare's dangerous gaps in addiction treatment coverage

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Bird flu outbreak in cows is latest avian flu curveball

State Dept. review finds Biden bears some blame for Afghanistan failures

MultiPlan and major insurers sued for alleged medical price

Moonlake's readout produced a cash windfall. Risks remain

Beware the threat of staffing cuts at the CDC

explore

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Getting Alzheimer's drug Leqembi to patients can be a challenge

Patient advocates sound warning on FDA proposal on salt intake

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Trump's false claims about Georgia's 2020 election long debunked

Diversity in clinical trials starts with building trust, experts say

Wikipedia

hotspot

leisure time

explore